Welcome, Guest. Please login or register.
July 18, 2024, 04:37:13 pm

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 203
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 67
Total: 67


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Those Who Clear Hepatitis B Still Face Liver Cancer Risk  (Read 7892 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Those Who Clear Hepatitis B Still Face Liver Cancer Risk
« on: October 19, 2018, 10:25:08 am »
People with hepatitis B virus (HBV) who achieve clearance of their hep B surface antigen (HBsAg) maintain a risk, albeit low, of developing hepatocellular carcinoma (HCC, the most common form of liver cancer) and therefore should be monitored periodically.

Publishing their findings in the Journal of Viral Hepatology, researchers conducted a systematic review of 28 studies that included more than 105,411 people with chronic HBV. A total of 7,656 of them spontaneously cleared the virus while another 1,248 achieved viral clearance after treatment with interferon or a nucleoside/nucleotide analogue medication. Overall, 6.77 percent of the cohort achieved HBsAg clearance.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.